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Abstract
Background: Maternal effect mutations in the components of the subcortical maternal complex (SCMC) of the
human oocyte can cause early embryonic failure, gestational abnormalities and recurrent pregnancy loss.
Enigmatically, they are also associated with DNA methylation abnormalities at imprinted genes in conceptuses: in
the devastating gestational abnormality biparental complete hydatidiform mole (BiCHM) or in multi-locus
imprinting disease (MLID). However, the developmental timing, genomic extent and mechanistic basis of these
imprinting defects are unknown. The rarity of these disorders and the possibility that methylation defects originate
in oocytes have made these questions very challenging to address.
Methods: Single-cell bisulphite sequencing (scBS-seq) was used to assess methylation in oocytes from a patient with
BiCHM identified to be homozygous for an inactivating mutation in the human SCMC component KHDC3L. Genome-
wide methylation analysis of a preimplantation embryo and molar tissue from the same patient was also performed.
Results: High-coverage scBS-seq libraries were obtained from five KHDC3Lc.1A>G oocytes, which revealed a genome-wide
deficit of DNA methylation compared with normal human oocytes. Importantly, germline differentially methylated regions
(gDMRs) of imprinted genes were affected similarly to other sequence features that normally become methylated in
oocytes, indicating no selectivity towards imprinted genes. A range of methylation losses was observed across genomic
features, including gDMRs, indicating variable sensitivity to defects in the SCMC. Genome-wide analysis of a pre-implantation
embryo and molar tissue from the same patient showed that following fertilisation methylation defects at imprinted genes
persist, while most non-imprinted regions of the genome recover near-normal methylation post-implantation.
Conclusions:We show for the first time that the integrity of the SCMC is essential for de novo methylation in the female
germline. These findings have important implications for understanding the role of the SCMC in DNA methylation and for
the origin of imprinting defects, for counselling affected families, and will help inform future therapeutic approaches.
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Background
The subcortical maternal complex (SCMC), a multi-
protein structure of the mammalian oocyte, orchestrates
a number of essential cellular processes during the
oocyte-to-embryo transition, such as spindle assembly,
chromosome alignment and symmetric cell division in
cleavage-stage embryos [1, 2]. In humans, mutations in
SCMC proteins cause various developmental abnormal-
ities, including early embryonic arrest and reproductive
failure [3–9]. A recurrent, but unexplained, finding is ab-
normalities in genomic imprinting. Maternal recessive
mutations in NLRP7 and KHDC3L, both indicated to en-
code SCMC components [3, 4, 10, 11], are the predom-
inant cause of biparental, complete hydatidiform mole
(BiCHM; also referred to as recurrent, familial hydatidi-
form mole; OMIM 231090 and 614293), a rare gesta-
tional abnormality characterised by trophoblast
overgrowth and absence of embryo development. NLRP7
or KHDC3L mutations are found in the majority of
BiCHM cases (NLRP7 ~ 75%, KHDC3L 5–10%) and are
associated with widespread loss of methylation (LoM) of
germline differentially methylated regions (gDMRs) of
imprinted genes in molar tissue [3, 4, 12, 13]. In
addition, mutations in other SCMC components, includ-
ing PADI6, OOEP, NLRP5 and NLRP2, have been de-
scribed in single imprinting syndromes or multi-locus
imprinting disturbance (MLID), and PADI6 has been as-
sociated with molar pregnancies [5, 8, 14]. However, the
molecular aetiology of BiCHM and MLID is obscure, as
connections between the SCMC under the oocyte
plasma membrane and the nuclear DNA methylation
machinery have not been defined. This lack of molecular
understanding prevents a meaningful development of
therapeutic approaches or satisfactory counselling of af-
fected families. Mouse models have thus far not been in-
formative, because there are no direct homologues of
KHDC3L or NLRP7, and because maternal effect muta-
tions in Nlrp5/Mater, Ooep/Floped and Tle6 lead to very
early developmental arrest [1, 15, 16]. Analysis of a
mouse Nlrp2 knockout, which is compatible with devel-
opment to term but with reduced fertility, has implicated
a defect in methylation maintenance of imprinted genes
post-fertilisation. It was shown that localisation of the
maintenance DNA methyltransferase DNMT1 with the
SCMC is disrupted in Nlrp2 knockout oocytes while
DNMT3A, the predominant methyltransferase respon-
sible for de novo methylation in the oocyte, retains nor-
mal chromosome association [17]. However, while mid-
gestation embryos and neonates from Nlrp2-deficient
oocytes exhibit limited methylation alterations of some
imprinted genes, there is no generalised LoM of imprints
typical of molar tissue [17]. Furthermore, with the rarity
of BiCHM, especially with a KHDC3L mutation, and be-
cause patients do not benefit from assisted reproduction
techniques other than egg donation, human oocyte or
early embryo material to study the origins of BiCHM
and MLID has been even more difficult to obtain.
Therefore, until now, there has been no assessment of
whether DNA methylation defects occur in oocytes ei-
ther in mouse models or human cases. Amongst the key
outstanding questions are (1) whether there is a defect-
ive establishment of methylation in oocytes or a failure
to maintain methylation specifically at imprinted loci in
pre-implantation embryos during genome-wide erasure
of gametic methylation and (2) whether LoM is limited
to imprinted loci or is more widespread. All these possi-
bilities could pertain because, in addition to undergoing
genome-wide de novo methylation [18], the oocyte pro-
vides the key factors required for the complex methyla-
tion reprogramming events in the cleavage-stage
embryo, including gDMR methylation maintenance [19,
20]. Genome-wide methylation analysis of BiCHM cases
with NLRP7 mutations using methylation arrays reveals
a widespread and apparently selective effect on
imprinted gDMRs [13], but this may not reflect the
methylation defect as it originates in the oocyte or pre-
implantation embryo, because molar tissues were exam-
ined after remethylation of the genome at implantation.
Until the development of single-cell genome-wide
methylation profiling (scBS-seq) [21], it has been impos-
sible to answer these long-standing questions. Here, we
had the unique opportunity to examine methylation
both in oocytes and molar tissue from the same patient
homozygous for a loss-of-function mutation in
KHDC3L. We found that DNA methylation establish-
ment in the oocyte was globally impaired and that this
LoM persisted at imprinted loci until post-implantation.
This is the first study to assess the origin of an imprint-
ing disorder in the human germline, demonstrating the
importance of the integrity of the SCMC for DNA
methylation establishment in the oocyte.
Methods
Patient details
Patient D was registered at the Mole Clinic of the Shiraz
University of Medical Sciences with a history of two suc-
cessive complete hydatidiform molar pregnancies and
identified by the Infertility Research Centre for subse-
quent mutation testing. A KHDC3L mutation was con-
firmed using Sanger sequencing.
Tissue sample preparation
A tissue sample from one of the molar conceptuses and
an endometrium tissue sample from patient D were col-
lected and formalin-fixed paraffin-embedded (FFPE) for
further analysis. As controls, FFPE tissue samples were
obtained from the placenta from two control patients, as
well as maternal endometrium and molar tissue from a
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patient with a sporadic case of androgenic complete
hydatidiform mole (AnCHM). DNA was extracted using
the QIAamp DNA FFPE Tissue Kit (Qiagen), and con-
tamination of molar tissue was tested by Chromoquant
QF-PCR kit (CyberGene AB).
Oocyte collection and ICSI procedure
Oocytes were obtained voluntarily from patient D at the
IVF centre of the Ghadir Mother and Child Hospital affili-
ated to Shiraz University of Medical Sciences with signed
informed consent of the patient and her husband and the
approval of the Ethics Committee of Shiraz University of
Medical Sciences (ethics codes: IR.sums.rec.1395.S718 for
oocyte retrieval and IR.sums.rec.1396.S779 for embryo
production). Mature oocytes were obtained after ovar-
ian stimulation using a standard gonadotropin-
releasing hormone (GnRH) antagonist protocol. Oo-
cytes were collected in G-IVF plus (Vitrolife) and
cleaned in G-MOPS (Vitrolife) supplemented with 80
IU/ml hyaluronidase (HYASE-10X, Vitrolife). Out of
nine oocytes, seven were collected for subsequent
scBS-seq analysis. Intracytoplasmic sperm injection
(ICSI) was performed followed by 6 days embryo cul-
ture with the two remaining oocytes, resulting in one
embryo, which was collected in < 5 μl RLT buffer for
whole-embryo BS-seq analysis.
DNA methylation array
DNA methylation of FFPE tissue samples was analysed
by chip array. DNA was sodium bisulphite treated using
the EZ DNA Methylation Kit (D5001, Zymo Research).
Single-strand bisulphite-converted DNA was quantified
with the NanoPhotometer Pearl (Implen GmbH), and
DNA length was restored using the Infinium HD FFPE
Restore Kit (WG-321-1002, Illumina). Genome-wide
methylation was performed on the Infinium Methylatio-
nEPIC Bead Chip (WG-317-1001, Illumina) following
Infinium HD FFPE Methylation Assay instructions and
using Illumina-supplied reagents and conditions. Fluor-
escence intensities were captured using Illumina HiScan
SQ (Illumina). The methylation profiles of 2 of the 11
control placentas were processed together with the sam-
ples of the KHDC3Lc.1A>G and AnCHM patient. The
other 9 control placentas were processed separately.
DNA methylation array analysis
The chip array data were analysed using R (v. 3.5.3). Beta
values were extracted from ‘idat’ files by using the ‘Load’
module of the ‘Champ’ R package (v. 2.12.0) [22], with
quality control options set as default. After this quality
control step, 745,259 probes were retained and used for
further analysis. SWAN normalisation [23] was applied,
with the ‘method’ option set to ‘minfi’. The SWAN-
normalised samples were assigned with respective gen-
ome coordinates based on probe name and manifest file
(Illumina). The coordinates for the array data were then
converted to human genome version hg38 (GRCh38)
using CrossMap (version 0.2.5) [24].
A genome-wide analysis was performed with a tile-
based approach using the ‘makewindows’ parameter of
bedtools (v2.25.0) [25] to generate fixed-sized 20-kb con-
secutive genome windows to compare across samples
(n = 160,724) of which 101,127 were retained after the
intersection with the array data. Further filtering was ap-
plied to ensure a minimum of 3 informative CpGs cov-
ered by the array per 20-kb window. Only windows with
the required minimal coverage in all samples were taken
into account, resulting in the assessment of 65,339 win-
dows (64.6%).
To analyse DNA methylation of imprinted DMRs,
annotations of gDMRs were taken from Sanchez-
Delgado et al. [13] and Hanna et al. [26] and cate-
gorised as described in Additional file 1: Table S1.
The coordinates of the array data were intersected
with DMRs viz. classic maternal and paternal gDMRs,
placenta-specific gDMRs and secondary DMRs using
bedtools. Probes over CpG islands (CGIs) were
defined using CpG island features from EnsEMBL
v90. Placenta methylated (> 70%) and unmethylated
(< 20%) CGIs were filtered using publically available
whole-genome bisulphite sequencing (WGBS) DNA
methylation data of placenta [27] as a reference. Non-
CGI regions were called by filtering 20-kb windows
that were not overlapping CGIs. To analyse the DNA
methylation loss in different genomic regions, genome
features from EnsEMBL v90 were used. Plots were
generated using the R packages ggplot2 for the scatter
plot and PCA, gplots (heatmap.2 function) for heatmaps
and ggpubr R package for boxplots. The methylation pro-
file in array data was visualised using the UCSC genome
browser (GRCh38). Hypomethylated regions in the
KHDC3Lc.1A>G mole were defined as 20-kb windows with
a mole/control placenta methylation ratio of < 0.65 and at
least ten covered CpGs per window.
Pyrosequencing
DNA from FFPE tissues was bisulphite converted using the
EpiTect Bisulfite Kit (Qiagen). Methylation analysis (CpG)
pyrosequencing assays were designed with PyroMark Assay
Design SW 2.0. Primers sequences are listed in Add-
itional file 2: Table S2. The PyroMark PCR kit (Qiagen) was
used to amplify 200 ng of converted DNA. Quantitative
DNA methylation analysis was performed using the Pyro-
Mark Q48 Autoprep, according to the manufacturer’s in-
structions (Qiagen). The results were analysed with the Q-
CpG software (V.1.0.9Pyrosequencing).
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Bisulphite sequencing
DNA methylation of single oocytes was assessed using
WGBS according to the single-cell adaptation (scBS-seq)
of the post-bisulphite adaptor tagging (PBAT) method as
previously described [21, 28]. The PBAT protocol was also
employed to analyse DNA methylation of the embryo,
using a slightly adapted method for bulk samples as de-
scribed elsewhere [29]. Single-cell libraries were amplified
for 14 cycles, and the embryo library was amplified for 12
cycles. Libraries were sequenced on the Illumina MiSeq to
assess library quality and to screen for somatic cell con-
tamination. Good-quality libraries were then sequenced
deeper on the Illumina NextSeq platform.
Public datasets
As controls for our DNA methylation data, we used publi-
cally available datasets. Raw sequencing reads were ob-
tained from DDBJ and GEO databases (https://www.ddbj.
nig.ac.jp/index-e.html and https://www.ncbi.nlm.nih.gov/
geo/) for the following datasets and processed with the pa-
rameters detailed below: bulk DNA methylation from oo-
cytes, sperm and blastocysts (accession DRP002710) [30];
single-cell DNA methylation from oocytes and embryos
(accession GSE81233) [31]; bulk DNA methylation from
the placenta (accession GSM1186665) [27]; and single-cell
RNA sequencing from oocytes (accession GSE44183) [32].
Library mapping and trimming
Raw fastq sequence files were initially quality trimmed
and adaptor trimmed with Trim Galore v0.4.2. Single-
cell data were trimmed with the ‘--clip_r1 9’ parameter
added in a single-end mode. Bulk PBAT data was
trimmed with the ‘--clip_r1 9’. RNA-seq data were
clipped with default parameters. Mapping and methyla-
tion calling of bisulphite sequencing data were per-
formed with Bismark v0.19.1 against the human
GRCh38 genome assembly. PBAT data were called using
the --pbat mode. Single-cell bisulphite data were called
using the --non_directional mode. RNA-seq data were
mapped against the human GRCh38 genome assembly
using Hisat2 v2.1.0 using --no-softclipping and --dta and
guided by splice junctions extracted from EnsEMBL v94.
DNA methylation sequencing analysis
DNA methylation was quantified in the KHDC3Lc.1A>G
oocytes and control oocytes in SeqMonk. Individual
KHDC3Lc.1A>G oocyte libraries were compared to pub-
lished single-cell libraries [31]. Since DNA methylation in
the KHDC3Lc.1A>G oocytes appeared similar, datasets were
grouped for part of the analysis to increase genome-wide
coverage of CpGs and compared to grouped single-cell
datasets of MII oocytes [31] and a bulk dataset of GV/MI
oocytes [30]. Using Seqmonk, a tile-based method was ap-
plied to bin consecutive genomic windows with a fixed
length (50 kb for single-cell and 20 kb for grouped ana-
lysis) to facilitate comparison across individual samples.
Methylation values were quantified with bisulphite se-
quencing pipeline quantification, which calculates per-
base methylation percentages and then averages these
within each window. Filters were applied to ensure a mini-
mum coverage of five or ten observed cytosines per probe
window for single-cell and grouped data analysis, respect-
ively. Only windows with the required minimal coverage
in all samples were taken into account, allowing for the as-
sessment of 26.6% of probes (n = 16,448) for single-cell
analysis and 92.1% of probes (n = 142,204) for grouped
data analysis. The initial quality of single-cell oocyte li-
braries was analysed by MiSeq using 100-kb overlapping
windows with a 10-kb step size. Methylated and unmethy-
lated domains were called using publically available DNA
methylation data in oocytes and sperm [30] as a reference.
Adjacent 10-kb windows with > 70% or < 30% DNA
methylation, respectively, were merged and filtered for a
size of ≥ 50 kb.
DNA methylation maintenance was analysed by calcu-
lating the embryo to oocyte methylation ratio, under the
assumption that perfect maintenance would be reflected
as a ratio of 0.5. Only the regions that had ≥ 20% re-
sidual methylation in KHDC3Lc.1A>G oocytes were in-
cluded in the maintenance analysis. Methylated domains
were filtered for those that were uniquely methylated in
one parental germline but not the other. Probes over
CGIs were defined using CpG island features from
EnsEMBL v90. Again, DNA methylation of control oo-
cytes was used to filter for methylated CGIs (> 70%) and
unmethylated CGIs (< 20%). Annotations of gDMRs are
listed in Additional file 1: Table S1. Genome features
used to assess DNA methylation loss were from
EnsEMBL v90. For analysis of repetitive elements, se-
quencing libraries were mapped against of prototypic
consensus sequences of repetitive DNA elements, ex-
tracted from Repbase in 2015 (https://www.girinst.org/
repbase/). Average DNA methylation for each element
was quantitated. Repetitive elements were grouped into
classes (ERV, L1, LTR, SINE, microsatellite repeats).
Microsatellite repeats were excluded from further ana-
lysis because of insufficient coverage. CpGs in ZFP57-
binding sites were defined as CpGs within the hexanu-
cleotide TGCCGC described by Quenneville et al. [33]
and alternative binding site GGCCGC from Anvar et al.
[34] that were contained within maternal gDMRs (390
binding sites). The percentage of methylated binding
sites was calculated for each single cell (control and
KHDC3Lc.1A>G).
Statistical analysis
Statistical analysis was conducted using GrapPad Prism
7 and R. Normal distribution of datasets was analysed
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using a Shapiro-Wilk normality test. DNA methylation
differences between KHDC3Lc.1A>G mole and control
placenta were analysed with a Wilcoxon signed-rank
test. Differences between KHDC3Lc.1A>G and control oo-
cytes in global CpG methylation and methylation of
ZFP57-binding sites were determined using an unpaired
two-tailed t test. The Wilcoxon signed-rank test was
employed to assess DNA methylation differences be-
tween KHDC3Lc.1A>G and control oocytes of methylated
and unmethylated domains, methylated and unmethy-
lated CGIs, and maternal gDMRs, as well as the DNA
methylation maintenance ratio. To determine the effect
size of DNA methylation changes in gDMRs, methylated
CGIs, unmethylated CGIs and non-CGI regions in
KHDC3Lc.1A>G mole and control placenta, a Brown-
Forsythe and Welsh ANOVA followed by Dunnett’s T3
multiple comparisons test were carried out.
Results
Methylation defects in biparental complete hydatidiform
mole caused by KHDC3L mutation
Patient D, a 27-year-old woman homozygous for a
confirmed loss-of-function mutation (A to G at the + 1 pos-
ition in start codon) in KHDC3L with multiple consanguin-
eous marriages in her extended family (Additional file 3:
Figure S1A,B), had a history of 2 BiCHMs. A sample of 1 of
these molar conceptuses with no evidence of contamination
from maternal tissue (Additional file 3: Figure S2A) was in-
vestigated. The presence of 2 alleles with balanced peaks for
each informative microsatellite marker analysed confirmed
that the molar tissue was derived from a biparental concep-
tus (Additional file 3: Figure S2A). Similar to patient D, the
husband and the KHDC3Lc.1A>G mole were found to be
homozygous for the KHDC3L mutation (Additional file 3:
Figure S1A and S2B); this result, which could be explained
by the parents’ consanguinity (Additional file 3: Figure S1B),
excludes the presence of normal KHDC3L in the conceptus
as well as in oocytes. We used the Illumina Human Methyla-
tionEPIC BeadChip array to assess the genome-wide DNA
methylation profile of the KHDC3Lc.1A>G mole as well as the
endometrium of patient D, an unrelated androgenetic mole
(AnCHM) and corresponding maternal endometrium, and 2
control placentas. After quality control filtering, methylation
data for ~ 745,000 CpG sites for each sample were obtained.
We also included methylation data from a further 9 control
placentas obtained independently on the same platform to
generate a robust control placenta dataset. The
KHDC3Lc.1A>G mole clustered with the AnCHM but separ-
ately from the control placentas and endometrium when
analysed by principal component analysis (PCA; Add-
itional file 3: Figure S3A). Analysis of 20-kb genomic win-
dows showed a reduction of CpG methylation levels in the
KHDC3Lc.1A>G mole compared to the control placenta
(Fig. 1a). However, the general pattern of DNA methylation
of the KHDC3Lc.1A>G mole was reminiscent of that of the
control placentas (Fig. 1b). Analysis of genomic features
showed that the majority of features, including genes, pro-
moters, exons, introns and intergenic regions, had a reduc-
tion in mean methylation of between 6.3 and 9.6% in the
KHDC3Lc.1A>G mole compared with the control placenta,
whereas no reduction was observed in CpG islands (CGIs;
Additional file 3: Figure S3B). We then specifically evaluated
methylated at imprinted gDMRs as listed in Additional file 1:
Table S1. For the purpose of this and subsequent analyses,
maternal gDMRs are defined as DMRs methylated in oocytes
but not in sperm and associated with known imprinted
genes (32 features); paternal gDMRs as DMRs methylated in
sperm but not oocytes and associated with known imprinted
genes (1 feature); placenta-specific gDMRs as CGIs methyl-
ated in oocytes but not sperm and retaining allelic differen-
tial methylation selectively in placenta (15 features [13];); and
secondary gDMRs as elements in known imprinted loci that
acquire allelic differential methylation after fertilisation (14
features). In contrast to the small decrease in methylation
throughout the genome, there was a substantial reduction in
methylation of many maternal gDMRs (23% on average), for
example, at the KCNQ1OT1 locus, whereas paternal gDMRs
retained normal methylation (e.g. H19) or increased methyla-
tion in the case of the secondary DMR at GNAS-NESP
(Fig. 1b–d, Additional file 3: Figure S3B,C). These methyla-
tion abnormalities were confirmed by pyrosequencing at
three maternal gDMRs, as well as the normal methylation at
the H19 paternal gDMR (Additional file 3: Figure S3D). The
reductions in maternal gDMR methylation in the
KHDC3Lc.1A>G mole were very similar to the AnCHM
(Fig. 1c, Additional file 3: Figure S3C) and to those described
previously for molar tissue arising from a mutation in NLRP7
[13]. The placenta methylome is characterised by intermedi-
ate methylation levels throughout the genome, with the ma-
jority of CGIs being unmethylated (12,889 CGIs < 10%) and
4062 CGIs being methylated (> 70%) [27]. In the
KHDC3Lc.1A>G mole, these characteristics are still evident,
and although methylated CGIs and non-CGI regions show
decreased DNA methylation, the reduction is significantly
less than at maternal gDMRs (Fig. 1e, Additional file 3: Fig-
ure S3E, Additional file 4: Table S3). It is possible that the
slight hypomethylation of these other genomic features re-
flects differences in cellular composition in the mole com-
pared with the control placenta.
These findings suggest that the KHDC3Lc.1A>G con-
ceptus is competent to methylate the genome as a whole
during the post-implantation remethylation phase, but
that any LoM in gDMRs that might have occurred in the
oocyte or preimplantation embryo cannot be fully re-
stored. To evaluate this further, we used the methylation
EPIC array data to identify regions with similar hypome-
thylation as observed for gDMRs in the KHDC3Lc.1A>G
mole compared to the control placentas. To do this, we
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filtered for 20-kb windows with a mole to control placenta
methylation ratio of < 0.65. This analysis identified 479
hypomethylated regions (Additional file 5: Table S4), cor-
responding to 1.9% of all 20-kb windows analysed (25,
030). Of the hypomethylated windows, 17 overlapped with
1 of the 47 primary maternal gDMRs that we included in
the study (Additional file 5: Table S4) and a further 27
overlapped with placenta-specific gDMRs identified by
Hanna et al. [26]. Together, these results suggest that
there is a preferential LoM of imprinted gDMRs in the
Fig. 1 DNA methylation analysis of molar tissue of a patient with a KHDC3L mutation. a Scatterplot of methylation values from the Illumina
Human MethylationEPIC BeadChip array of 20-kb windows in the KHDC3Lc.1A>G mole compared with the grouped control placentas (n = 11).
Highlighted are methylation levels of classic and placenta-specific maternal gDMRs. b UCSC browser screenshot of genomic methylation in
KHDC3Lc.1A>G mole compared with the control placentas (n = 11). The zoomed-in view shows methylation over the KCNQ1OT1 imprinted domain
with gDMR location highlighted in grey. Each vertical bar represents a single CpG on the array. c Heatmap showing methylation of maternal and
paternal gDMRs in the KHDC3Lc.1A>G mole, control placentas (n = 11) and AnCHM. d, e Box and whisker plots showing methylation in the control
placentas (n = 11) and KHDC3Lc.1A>G molar tissue at d maternal gDMRs (n = 43) and e placenta-specific methylated CGIs (n = 937), placenta-
specific unmethylated CGIs (n = 11,728) and non-CGI windows (n = 48,581). Boxes represent the interquartile range; lines, the median; and dots
beyond the whiskers, outliers. Comparisons in d and e are all statistically significant (p < 0.0001), although the effect size at maternal gDMRs is
significantly greater (Additional file 3: Fig. S3E). Detailed statistical measures are given in Additional file 4: Table S3
Demond et al. Genome Medicine           (2019) 11:84 Page 6 of 14
KHDC3Lc.1A>G mole, with the remainder of the genome
able to establish relatively normal levels of methylation.
Genome-wide DNA methylation deficit in KHDC3Lc.1A>G
oocytes
We next sought to evaluate genome-wide methylation in
oocytes from patient D. Following ovarian stimulation, 1
metaphase-I (MI) and 8 metaphase-II (MII) oocytes were
obtained (Additional file 3: Figure S4A), of which the MI
and 6 MII oocytes were processed by scBS-seq. Initial
sequencing indicated that 5 of the MII oocytes yielded
acceptable scBS-seq libraries with no evidence of cumu-
lus cell DNA contamination (Additional file 3: Figure
S4B,C). These 5 libraries were then sequenced to satur-
ation, obtaining reads covering 3,249,800–4,354,472
CpG sites or 11.3–15.1% of the genomic total per single-
cell library and 43.98% CpG coverage after combining
datasets (Additional file 6: Table S5). The scBS-seq data
were compared with a published deeply sequenced
methylome of bulk germinal vesicle (GV)/MI oocytes
[30] and 32 single MII oocyte datasets [31], the latter
generated by an equivalent single-cell protocol.
The KHDC3Lc.1A>G oocytes had similarly and substan-
tially reduced global CpG methylation levels compared
with control MIIs (median 22.9% versus 37.1%; Fig. 2a,
Additional file 3: Figure S5A, Additional file 4: Table S3)
and were clearly separated from control oocytes by PCA
(Additional file 3: Figure S5B). In comparison, no signifi-
cant differences were observed for non-CpG methylation
(Additional file 3: Figure S5C). Because methylation was
similarly affected in the KHDC3Lc.1A>G oocytes (Fig. 2a,
Additional file 3: Figure S5A), most subsequent analysis
was done after merging the 5 datasets. Analysis of 20-kb
genomic windows showed that the methylation loss in
KHDC3Lc.1A>G oocytes was observed throughout the en-
tire genome, although not every window was affected to
the same degree (Fig. 2b). Human oocytes have a dis-
tinctive methylation pattern, with coherent domains of
high methylation associated with active transcription
units and domains of low methylation over non-
transcribed regions [30]. This general pattern was pre-
served in the KHDC3Lc.1A>G oocytes (Fig. 2c); however,
the methylation level of hypermethylated domains was
substantially reduced (median 49.1% versus 84.4% in
controls; Fig. 2d, Additional file 4: Table S3). We also
evaluated methylation of CGIs, which is distinctive in
oocytes: 2614 of 22,564 CGIs are normally highly meth-
ylated (≥ 70%) in oocytes [30]. Similar to the hyper-
methylated domains, we found an overall reduction in
the methylation of these CGIs (median 53.4% compared
with 88.3% in controls; Fig. 2e). When we assessed the
maternal gDMRs of imprinted genes, we also found a
substantial reduction in methylation of a similar magni-
tude (median 84.7% in controls, 45.4% in KHDC3Lc.1A>G
oocytes; Fig. 2f, Additional file 4: Table S3). Overall, all
genomic features seemed to be losing DNA methylation
to a similar extent, although the maternal gDMRs were
affected slightly more (Additional file 3: Figure S6A). To
test whether maternal gDMRs were actually more af-
fected by LoM than other genomic regions, we identified
regions with similar CpG density and methylation levels
as maternal gDMRs in control oocytes. Indeed, the aver-
age LoM of gDMRs was significantly greater than the
comparable control genomic regions (Additional file 3:
Figure S6B). Like other genomic elements, imprinted
gDMRs were variably affected in KHDC3Lc.1A>G oocytes,
with some loci lacking methylation and others retaining
> 50% methylation (Fig. 2f, g). This indicates variable
sensitivity to loss of SCMC integrity, but the causes of
this variation are unclear. To assess the variation in
LoM, we calculated the standard deviation of methyla-
tion values of genes and of random, genome-wide 50
CpG windows. The variation in LoM did not appear to
be completely random, in that the variation within genes
was less than the genome-wide variation (Add-
itional file 3: Figure S6C). However, despite the strong
association between methylation establishment and tran-
scription in oocytes [30, 35], the magnitude of LoM was
not correlated with transcription level (as inferred from
single-cell RNA-seq datasets from healthy oocytes [32];
Additional file 3: Figure S6D). We also assessed the
DNA methylation levels in repetitive regions of the gen-
ome and found small, but significant, methylation losses
in endogenous retroviral elements (ERVs), L1 long-
interspersed nuclear elements (LINEs, L1) and short-
interspersed nuclear elements (SINEs), whereas no sig-
nificant changes were observed in long-terminal repeats
(LTRs; Additional file 3: Figure S6E).
Because the scBS-seq data do not provide full genome
coverage, we did not expect to be able to evaluate
methylation of all gDMRs individually in all oocytes.
Nevertheless, after setting a coverage threshold of ≥ 10
CpGs/gDMR, we were able to call methylation in at least
2 oocytes for 42 gDMRs (26–33 gDMRs per oocyte).
This revealed that many gDMRs exhibited similar LoM
(e.g. ZC3H12C, KCNQ1OT1) in all informative oocytes,
while some of those with partial LoM when analysed in
the pooled data (Fig. 2g) displayed variation in methyla-
tion loss between oocytes (e.g. PEG3, PEG10;
Additional file 3: Figure S7A). This analysis also
indicated that some oocytes exhibited greater gDMR
LoM overall than others (e.g. MII-6; Additional file 3:
Figure S7A,B). Finally, we assessed methylation at bind-
ing site motifs within maternal gDMRs for the zinc-
finger protein ZFP57 [33, 34], which selectively binds a
methylated recognition sequence and is one of the fac-
tors required for post-fertilisation maintenance of gDMR
methylation [36, 37]. ZFP57-binding motifs also
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Fig. 2 (See legend on next page.)
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exhibited a reduced rate of methylation in KHDC3Lc.1A>G
oocytes, of a similar magnitude to the loss at gDMRs
(Fig. 2h).
Genome-wide DNA methylation analysis of a
KHDC3Lc.1A>G blastocyst
The remaining 2 MII oocytes were subject to intra-
cytoplasmic sperm injection from which 1 embryo devel-
oped in vitro until the late morula/early blastocyst stage at
day 6 (Additional file 3: Figure S8A) when it was collected
for methylation analysis. Despite being developmentally
less advanced than normal blastocysts, the KHDC3Lc.1A>G
embryo had reduced methylation in comparison with con-
trol blastocysts [30] (median methylation of 20-kb win-
dows 19.4 versus 28.3%; Fig. 3a, b) and did not cluster
with any embryonic stage by PCA (Additional file 3:
Figure S8B), suggesting an anomalous methylation pat-
tern. Maternal gDMRs showed variable LoM, as they did
in oocytes. (Additional file 3: Figure S8C). A residual, gene
body methylation pattern inherited from oocytes is
apparent in control blastocysts, and this pattern appears
attenuated in the KHDC3Lc.1A>G embryo (Fig. 3b), as it
does in KHDC3Lc.1A>G oocytes. We inferred the fidelity of
methylation maintenance at those gDMRs that had ≥ 20%
residual methylation in KHDC3Lc.1A>G oocytes by calcu-
lating the embryo to oocyte methylation ratio, assuming
that perfect maintenance would be reflected as a ratio of
0.5. For maternal gDMRs, the actual figure was 0.44 in
control blastocysts, but only 0.32 in the KHDC3Lc.1A>G
embryo (median of 38 gDMRs; Fig. 3c, Additional file 4:
Table S3). CGIs exclusively methylated in oocytes (mater-
nal methylated CGIs) showed a similar deficit, whereas
other sequence features methylated in oocytes (maternal
methylated domains) or methylated in sperm (paternal
methylated domains and CGIs) were less affected (Fig. 3c).
The further reduction in gDMR and maternally methylated
CGI methylation in the KHDC3Lc.1A>G embryo could indi-
cate a role for the SCMC also in methylation maintenance
mechanisms. However, when we evaluated methylation at
gDMRs in the KHDC3Lc.1A>G mole, there tended to be a
maintenance of the residual levels of methylation from the
oocyte (Fig. 3d).
Discussion
Here, for the first time, we show that an SCMC defect
causing BiCHM results in a genome-wide methylation
deficit in oocytes. This demonstrates an important appli-
cation of single-cell bisulphite sequencing in obtaining
high-resolution DNA methylation data from very rare
material. With the genome-wide coverage obtained, we
were able to answer key questions relating to the origins
of methylation defects in BiCHM that could not previ-
ously be addressed. Importantly, we identified that ma-
ternal gDMRs were affected to a similar magnitude as
other sequence features that become methylated de novo
in oocytes, demonstrating that there is no specificity of
the primary defect towards imprinted loci. A primary ef-
fect in female gametes is consistent with earlier reports
that methylation at the H19 paternal gDMR is un-
affected in BiCHM [12]. That BiCHM tissue in compari-
son has a generally preserved methylation status, apart
from imprinted gDMRs, indicates that these conceptuses
are competent for de novo methylation of the genome
after implantation, but that defective methylation at
gDMRs arising in oocytes cannot be rescued. We also
observed a further reduction in gDMR methylation in
the single KHDC3Lc.1A>G preimplantation embryo we
were able to assess, which could indicate a role for the
integrity of the SCMC also in methylation maintenance
mechanisms. Alternatively, the incomplete methylation
of CGIs and gDMRs in oocytes, particularly at ZFP57
sites assumed to be critical for methylation maintenance,
might allow further erosion of methylation in the preim-
plantation embryo during the phase of genome-wide
methylation reprogramming. We should note, however,
that we were only able to assess a single KHDC3Lc.1A>G
preimplantation embryo, which might not be competent
for implantation and further development, and may
(See figure on previous page.)
Fig. 2 Genome-wide deficit in DNA methylation in KHDC3Lc.1A>G oocytes. a Global CpG methylation as determined by scBS-seq in KHDC3Lc.1A>G MII
oocytes (n = 5) compared with PBAT from a bulk population of control GV/MI oocytes (denoted by Okae et al. [30]) and scBS-seq of MII oocytes (n =
32, denoted by Zhu et al. [31]). Indicated are mean methylation levels for each single oocyte (dots) and the median of each group. b Scatterplot of
methylation values of 20-kb windows in grouped KHDC3Lc.1A>G oocytes (n = 5) compared with grouped control oocytes (Zhu et al. [31]; n = 32). c
Seqmonk browser screenshot of genomic methylation in grouped KHDC3Lc.1A>G oocytes (n = 5) compared with bulk (Okae et al. [30]) and grouped
(Zhu et al. [31]; n = 32) control oocytes. The zoomed-in view shows methylation over the KCNQ1OT1 imprinted domain. Each vertical bar in both
zoomed-out and zoomed-in views is a 20-kb window, height and colour-coded for % methylation. d–f Box and whisker plots showing methylation in
grouped control (Zhu et al. [31]; n = 32) and KHDC3Lc.1A>G oocytes (n = 5) of oocyte methylated and unmethylated domains (d), methylated and
unmethylated CpG islands (CGIs; > 70 and < 20% in control oocytes, respectively) (e) and maternal gDMRs (f). Boxes represent the interquartile range;
lines, the medians; whiskers, the 1.5× the interquartile range; dots beyond the whiskers, outliers. The numbers of features per category are given in
Additional file 4: Table S3. g Heatmap showing methylation of maternal gDMRs in grouped KHDC3Lc.1A>G oocytes (n = 5) and bulk GV/MI (Okae et al.
[30]) or grouped MII (Zhu et al. [31]; n = 32) control oocytes. h Stripcharts reporting percentage of methylated CpG sites (115) in ZFP57 binding motifs
overlapping 32 maternal gDMRs in each single oocyte of control (Zhu et al. [31]; n = 32) and KHDC3Lc.1A>G oocytes (n = 5). Dots represent the mean
methylation % of all the ZFP57-CpG sites measured in a single oocyte, lines the median of each group. Comparisons in a and d–h are all statistically
significant (p < 0.0001). Detailed statistical measures are given in Additional file 4: Table S3
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therefore manifest more severe methylation defects than
an embryo from which molar tissue could arise.
How could a defect in the SCMC—or in the protein
components—impair DNA methylation establishment in
the oocyte? The mechanisms of de novo methylation in
oocytes are best understood in the mouse, benefitting
from genetic manipulations [18]. De novo methylation
takes place on a genome largely demethylated after spe-
cification of primordial germ cells, in the latter stages of
oocyte growth (secondary to antral follicle stage), and
culminates in a distinctive methylation landscape with
methylation preferentially over expressed gene bodies
[21, 30, 35, 38]. Imprinted gDMR methylation is part of
this generalised transcription-dependent mechanism [35,
39, 40]. Successful methylation establishment involves
the interplay of several nuclear processes. In mice, the
required de novo methyltransferase proteins DNMT3A
and DNMT3L become abundant in oocytes concomitant
with the onset of methylation [41]. Genomic recruitment
of DNMT3A/DNMT3L is assumed to depend upon an
appropriate chromatin state. DNA methylation coincides
with domains of enrichment of histone 3 lysine 36 tri-
methylation (H3K36me3) over expressed genes, depos-
ited by the unique H3K36me3 methyltransferase SETD2
[42]. Conversely, the histone mark H3K4me3 conven-
tionally enriched at active promoters is antagonistic to
DNMT3A/3L recruitment and activity [43, 44], and re-
moval of H3K4 methylation at gDMRs requires
Fig. 3 Methylation abnormalities in a KHDC3Lc.1A>G embryo. a Scatterplot comparing methylation determined by PBAT in a single whole
KHDC3Lc.1A>G preimplantation embryo with PBAT of a bulk population of control blastocysts (Okae et al. [30]). Each point is a 20-kb window. b
Screenshot of methylation in the KCNQ1OT1 imprinted domain in control blastocysts (Okae et al. [30]) and the KHDC3Lc.1A>G embryo. Each vertical
bar is a 20-kb window, height and colour-coded for % methylation. c Box and whisker plots comparing ratio of methylation maintenance in
control blastocysts and the KHDC3Lc.1A>G embryo at maternal gDMRs retaining ≥ 20% DNA methylation in the oocyte (n = 38), maternal-
methylated domains (n = 285), paternal-methylated domains (n = 2471), maternal-methylated CGIs (n = 735) and paternal-methylated CGIs (n =
299). d Box and whisker plots comparing methylation maintenance ratio in control blastocysts and the KHDC3Lc.1A>G mole at maternal and
placenta-specific gDMRs (n = 40) retaining ≥ 20% DNA methylation in KHDC3Lc.1A>G oocytes. In c and d, boxes represent the interquartile range;
lines, the medians; whiskers, the 1.5× the interquartile range; and dots beyond the whiskers, outliers. Comparisons in c and d are all statistically
significant (p = 0.0125 for maternal gDMRs in c and p < 0.0001 for all others). Detailed statistical measures are given in Additional file 4: Table S3
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transcription-coupled nucleosome remodelling and/or
activity of H3K4 demethylases such as KDM1B [35, 45,
46]. The normal methylation pattern also depends upon
the exclusion of DNMT1 and its auxiliary protein
UHRF1 from the nucleus, which otherwise leads to
methylation of intergenic regions: this nuclear exclusion
depends on the protein STELLA/PGC7 [47]. How could
the global effect on methylation we observe in
KHDC3Lc.1A>G oocytes be explained? Considering the
major role of transcription in specifying methylation in
oocytes, a global problem in transcription could lead to
a generalised deficit in methylation; however, this seems
unlikely, as a major effect on transcription sufficient to
attenuate methylation to the magnitude observed would
likely be incompatible with full development and matur-
ation of the oocyte. RNA-seq analysis of KHDC3Lc.1A>G
oocytes would be required to determine whether tran-
scription defects could account for the variable methyla-
tion loss across maternal gDMRs and other genomic
features. Gross reductions in the abundance or nuclear
localisation of some of the key players above, such as
DNMT3A or SETD2, could also cause the effects ob-
served. However, loss of SETD2 in mouse oocytes, in
addition to abrogating gene body methylation, leads to
substantial methylation gain in intergenic regions [42],
which we do not observe in the KHDC3Lc.1A>G oocytes.
The involvement of STELLA in sequestering DNMT1/
UHFR1 from the nucleus [47] demonstrates the import-
ance of regulated subcellular localisation of selected epi-
genetic factors in the oocyte. Conceivably, therefore,
normal nuclear localisation of DNMT3A/3L—or other as-
sociated factors—in growing oocytes could depend upon
an intact SCMC. However, mouse oocytes genetically ab-
lated for the SCMC component NLRP2 are reported to
have normal nuclear staining of DNMT3A [17], but they
are also unlikely to have such pervasive methylation de-
fects. Moreover, neither Dnmt3a or Dnmt3L is haploin-
sufficient in mouse oocytes, indicating that their nuclear
availability would need to be reduced to below 50% of
normal levels to substantially affect de novo methylation
[48, 49]. One mouse gene knockout that phenocopies the
global methylation defect of KHDC3Lc.1A>G oocytes is the
oocyte-specific ablation of the histone H3 chaperone
HIRA [50]. HIRA is responsible for continuous replace-
ment of H3/H4 during oogenesis, particularly associated
with transcription. In addition to grossly diminished de
novo methylation, Hira-deficient oocytes are severely
compromised in ovulation, developmental competence,
and chromosome compaction and segregation [50], evi-
dence of the importance of chromatin regulation during
oogenesis. It is also important to bear in mind the poten-
tial differences between humans and mice in relation to
de novo methylation mechanisms in oocytes [18]. Al-
though the striking gene body methylation pattern is
conserved, a recent study found differences in the histone
regulatory landscape in human compared to mouse oo-
cytes [51], and DNMT3L, an essential co-factor for
DNMT3A in the mouse oocyte [48, 52, 53], is not
expressed in human oocytes [30, 54]. Furthermore, be-
cause KHDC3L, as well as other SCMC members such as
NLRP7, do not have mouse orthologues, studying the
functional mechanisms by which the SCMC regulates de
novo DNA methylation remains challenging.
It was notable that the maternal gDMRs in the
KHDC3Lc.1A>G oocytes, preimplantation embryo and
mole exhibited a range of LoM; in addition, there was
evidence that individual KHDC3Lc.1A>G oocytes varied in
the severity of gDMR LoM. In comparison, molar tissue
from women of the first reported KHDC3L pedigree had
complete LoM at the few gDMRs evaluated [12]. At
present, we do not know the reason for this variation in
methylation loss. Similar to our patient D, the mutation
in the original pedigree was identified in the initiation
codon of KHDC3L, but at the + 3 position [4, 12]. In
transfections, Parry and co-workers demonstrated the
use of the next available in-frame ATG codon (at pos-
ition 14) for translation of an amino-terminally trun-
cated protein from this mutation [4]. If some residual,
truncated protein were translated in vivo, or if other
SCMC proteins partially compensate for the loss of
KHDC3L, this could account for the partial LoM we ob-
serve. Alternatively, if KHDC3L deficiency results in a
structural defect in the SCMC that impairs the normal
localisation or activity of factors essential for methyla-
tion, it might manifest at a time in oocyte growth when
de novo methylation is already in progress, such that it
attenuates rather than completely prevents methylation.
Consistent with this possibility, studies in mice indicate
there is asynchrony in the acquisition of methylation of
gDMRs and CGIs during oocyte growth [55–57], and re-
cent single-cell analysis of growing and fully-grown oo-
cytes shows some heterogeneity amongst oocytes in
methylation of maternal gDMRs [58]. This has some
similarity with the variation in gDMR methylation we
observe in KHDC3Lc.1A>G oocytes, again consistent with
the notion that the progression of de novo methylation
during oocyte growth is impaired. Future analysis of the
de novo methylation process during normal human oo-
genesis, as well as knowledge of the timing of elabor-
ation of the SCMC, may help resolve this issue.
Conclusions
In conclusion, we show that a mutation causing BiCHM
results in a substantial and generalised reduction in
methylation in oocytes, together with impaired mainten-
ance of gDMR methylation during preimplantation de-
velopment, and persistence of methylation defects
preferentially at imprinted loci post-implantation. The
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discovery of a primary oocyte defect will now focus at-
tention on how the mechanism of methylation establish-
ment is globally impaired by defects in the SCMC. It
also has important implications for possible therapeutic
interventions in patient oocytes; these would be very
challenging and, if to be considered, would have to aim
to restore de novo methylation during oocyte growth,
perhaps by injection of KHDC3L cRNA into oocytes
growing in in vitro follicle culture systems [59–61].
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